One of the first frontiers of CRISPR gene editing is targeting diseases related to the eye. A diverse Morgridge and UW-Madison team is working to make future applications precise, safe and reproducible.
Pancreatic cancer is a rare, yet elusive and deadly cancer, with a five-year survival rate of about 10%. If the cancer has metastasized, that rate lowers to 3%. And treatment options are extremely limited.
Non-invasive imaging method can predict the efficiency of cardiomyocyte differentiation news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.